CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.
December 2nd 2022
From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.
November 30th 2022
For National Family Caregivers Month, lymphoma caregiver Rickey Briskman explains the importance of caregivers putting themselves first.
November 23rd 2022
The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.
November 18th 2022
From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.
October 14th 2022
Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.
September 9th 2022
From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.
July 19th 2022
A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
June 28th 2022
Spring 2022 brought in some landmark blood cancer approvals from the FDA. Here is a roundup of the therapies recently approved by the FDA that patients may have missed.
June 24th 2022
From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.
May 11th 2022
The use of bendamustine and Rituxan plus autologous stem cell transplantation and maintenance Rituxan resulted in similar outcomes to other Rituxan-based regimens that are currently the standard of care for young patients with mantle cell lymphoma, a type of non-Hodgkin lymphoma, who are eligible for transplant.
February 25th 2022
An expert gives an overview of current standard of care and what’s coming down the pipeline in terms of treatment options for diffuse large B-cell lymphoma.
February 25th 2022
Treatment with TRPH-222 led to lasting responses in certain patients with relapsed/refractory B-cell non-Hodgkin lymphomas, warranting a larger investigation into the drug, according to the researchers.
February 23rd 2022
Nina Luker has shared her journey with diffuse large B-cell lymphoma on social media with more than 100,000 followers, but says she noticed a difference in the kinds of comments she received after treatment was over and she was deemed “not as vulnerable” anymore.
February 11th 2022
From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.
December 23rd 2021
New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.
December 21st 2021
“I had to choose one of two paths, to become the victim and let the disease control me or take control of the disease and fight for my life. The moment I chose to fight was the moment life opened all of its beauty,” writes a lymphoma survivor.
December 17th 2021
A non-Hodgkin’s lymphoma survivor writes about how she chose to approach a stressful doctor’s appointment and how doing whatever helps may look different for everyone.
December 12th 2021
Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.
November 26th 2021
Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.
November 18th 2021
Although the interest of at-home care including the administration of cancer infusions has grown since the start of the COVID-19 pandemic, hesitation looms over its convenience, cost and safety.
November 1st 2021
The Food and Drug Administration will review parsaclisib for the treatment of patients with follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma.
October 7th 2021
Caregivers of patients with cancer may face financial toxicity and stress — with little time to take care of themselves.
September 23rd 2021
The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.
September 22nd 2021
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
September 1st 2021
The FDA approval of Brukinsa, according to an expert from the Dana-Farber Cancer Institute, provides an important new option for targeted therapy in Waldenstrom’s macroglobulinemia.
August 6th 2021
A survivor shares how she chose to approach her mindset during cancer treatments to keep herself from spiraling.
July 29th 2021
Bayer, the manufacturer of Roundup, created a five-point plan to decrease the risk of facing future litigation about its product causing cancer.
July 26th 2021
About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.
July 16th 2021
From Ashley Monroe’s blood cancer diagnosis to a CrossFit athlete’s inspiring cancer journey, here’s what’s happening in the cancer landscape this week.